1/1
5 files

Effective Initiation and Treatment With Basal Insulin in People With Type 2 Diabetes: Focus on Mitigating Hypoglycemia in Patients at Increased Risk

media
posted on 14.01.2021, 17:01 by John Anderson, Geralyn R. Spollett, Paresh Dandona, Scott Urquhart

Many people with type 2 diabetes are treated with insulin with the goal of achieving a specific A1C target. In this short video series, an expert panel moderated by John Anderson, MD, discusses approaches to optimizing basal insulin initiation and treatment in people with type 2 diabetes, including those patients most at risk (e.g., those with renal impairment and older adults), with a focus on reaching A1C goals while mitigating the risk for hypoglycemia.

The panel discusses how considerations for the management of hypoglycemia are important in these patients. When used appropriately, the risk of hypoglycemia with basal insulin analogs can be reduced while still achieving individualized glycemic goals.

The videos can be viewed in their entirety here, and an executive summary of the panel’s recommendations is available on the Clinical Diabetes website at https://doi.org/10.2337/cd20-0035.

This peer-reviewed publication was developed in adherence with Good Publication Practice (GPP3) guidelines. All authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship and have disclosed all potential conflicts of interest.

Funding

Sanofi

History

Exports